Maja Di Rocco

@gaslini.org

Chief Unit Rare Diseases, Department of Pediatrics
IRCCS Istituto Giannina Gaslini

EDUCATION

Main Degree:Medicine and Surgery, Universitiy of Genoa, 1979
Postgraduated degree Pediatrics,University of Genoa 1984
Postgraduated degree Pediatric Neurology and Psychiatry ,University of Genoa, 1987

RESEARCH INTERESTS

Genetic diseases,
Metabolic diseases
283

Scopus Publications

13480

Scholar Citations

63

Scholar h-index

198

Scholar i10-index

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

  • Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: a plain language summary of a post hoc analysis of the LUMINA-1 trial
    R Keen, KM Dahir, J McGinniss, RJ Sanchez, S Mellis, AN Economides, ...
    Future Rare Diseases 6 (1), 2635334 , 2026
    2026
  • Mitochondrial energetic failure underlies FLVCR1-related sensory neuropathy
    F Bertino, DI Zanin Venturini, E Grasso, J Kopecka, C Salio, B Gnutti, ...
    Communications Biology , 2026
    2026
    Citations: 1
  • Hearing loss predictive model in fibrodysplasia ossificans progressiva from a national referral center: developing an hearing loss predictive model
    T Cacco, R Papa, L Carmisciano, C Bruzzo, L Semino, A Tonelli, ...
    JBMR plus 9 (4), ziaf029 , 2025
    2025
  • Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: a post hoc analysis of the randomized, double-blind, placebo …
    R Keen, KM Dahir, J McGinniss, RJ Sanchez, S Mellis, AN Economides, ...
    Journal of Bone and Mineral Research 39 (10), 1486-1492 , 2024
    2024
    Citations: 10
  • 3-3. OTHER SKELETAL ANOMALIES OF FOP
    RJ Pignolo, K Cheung, S Kile, MA Fitzpatrick, C De Cunto, ...
    THE FOP TREATMENT GUIDELINES 134, 15 , 2024
    2024
  • 5-12. DEVELOPMENTAL ARTHROPATHY AND DEGENERATIVE JOINT DISEASE IN FOP
    M Severino, M Bertamino, D Tortora, G Morana, S Uccella, R Bocciardi, ...
    THE FOP TREATMENT GUIDELINES 53, 85 , 2024
    2024
  • Dysregulation of FLVCR1a-dependent mitochondrial calcium handling in neural progenitors causes congenital hydrocephalus
    F Bertino, D Mukherjee, M Bonora, C Bagowski, J Nardelli, L Metani, ...
    Cell Reports Medicine 5 (7) , 2024
    2024
    Citations: 11
  • The effects of garetosmab in people with fibrodysplasia ossificans progressiva (FOP): A plain language summary of the LUMINA-1 study
    MD Rocco, R J Pignolo, R Keen, D Srinivasan, S J Mellis, M Davis, ...
    Future Rare Diseases 4 (1), FRD63 , 2024
    2024
  • Multicentric Carpo-Tarsal Osteolysis Syndrome (MCTO) and “Function Profile”: a rehabilitative approach
    AB Ronchetti, M Usai, V Savino, M Scaglione, CM Tacchino, M Bertamino, ...
    Orphanet Journal of Rare Diseases 18 (1), 392 , 2023
    2023
    Citations: 2
  • The Relationship of Flare-Ups and Heterotopic Ossification in Patients with Fibrodysplasia Ossificans Progressiva: LUMINA-1 Data
    R Keen, J McGinniss, E Forleo-Neto, S Mellis, K Dahir, M Di Rocco, ...
    JOURNAL OF BONE AND MINERAL RESEARCH 38, 71-71 , 2023
    2023
  • Flare-Ups in Patients with Fibrodysplasia Ossificans Progressiva Reduced by Garetosmab Treatment: LUMINA-1 Data
    K Dahir, J McGinniss, E Forle-Neto, S Mellis, R Sanchez, M Di Rocco, ...
    JOURNAL OF BONE AND MINERAL RESEARCH 38, 70-70 , 2023
    2023
  • OR29-06 Flare-Ups In Patients With Fibrodysplasia Ossificans Progressiva Reduced By Garetosmab Treatment: LUMINA-1 Data
    KM Dahir, J McGinniss, E Forleo-Neto, S Mellis, RJ Sanchez, M Di Rocco, ...
    Journal of the Endocrine Society 7 (Supplement_1), bvad114. 571 , 2023
    2023
  • Garetosmab in fibrodysplasia ossificans progressiva: a randomized, double-blind, placebo-controlled phase 2 trial
    M Di Rocco, E Forleo-Neto, RJ Pignolo, R Keen, P Orcel, ...
    Nature Medicine 29 (10), 2615-2624 , 2023
    2023
    Citations: 62
  • Screening for lysosomal diseases in a selected pediatric population: The case of Gaucher disease and acid sphingomyelinase deficiency
    M Di Rocco, CD Vici, A Burlina, F Venturelli, A Fiumara, S Fecarotta, ...
    Orphanet Journal of Rare Diseases 18 (1), 197 , 2023
    2023
    Citations: 10
  • GAU-PED study for early diagnosis of Gaucher disease in children with splenomegaly and cytopenia
    A Pession, M Di Rocco, F Venturelli, B Tappino, W Morello, N Santoro, ...
    Orphanet Journal of Rare Diseases 18 (1), 151 , 2023
    2023
    Citations: 12
  • Acid sphingomyelinase deficiency (ASMD): Addressing knowledge gaps in unmet needs and patient journey in Italy—A Delphi consensus
    M Scarpa, A Barbato, A Bisconti, A Burlina, D Concolino, F Deodato, ...
    Internal and Emergency Medicine 18 (3), 831-842 , 2023
    2023
    Citations: 11
  • Garetosmab, an inhibitor of activin A, reduces heterotopic ossification and flare-ups in adults with fibrodysplasia ossificans progressiva: A randomized, double-blind, placebo …
    M Di Rocco, E Forleo-Neto, R Pignolo, R Keen, P Orcel, ...
    medRxiv, 2023.01. 11.23284254 , 2023
    2023
    Citations: 6
  • Long-term bone outcomes in Italian patients with Gaucher disease type 1 or type 3 treated with imiglucerase: a sub-study from the International Collaborative Gaucher Group …
    MD Cappellini, F Carubbi, M Di Rocco, F Giona, G Giuffrida
    Blood Cells, Molecules, and Diseases 98, 102705 , 2023
    2023
    Citations: 18
  • Gene therapy for fibrodysplasia ossificans progressiva: feasibility and obstacles
    EMW Eekhoff, RD De Ruiter, BJ Smilde, T Schoenmaker, TJ De Vries, ...
    Human gene therapy 33 (15-16), 782-788 , 2022
    2022
    Citations: 20
  • Search for biomarkers and prognostic indicators of liver degeneration in glycogen storage disease type Ia
    R Resaz, D Cangelosi, D Segalerba, M Morini, MC Bosco, S Paci, A Sechi, ...
    Journal of Hepatology 77, S515 , 2022
    2022

MOST CITED SCHOLAR PUBLICATIONS

  • Characterization of human disease phenotypes associated with mutations in TREX1 , RNASEH2A , RNASEH2B , RNASEH2C , SAMHD1 , ADAR , and IFIH1
    YJ Crow, DS Chase, J Lowenstein Schmidt, M Szynkiewicz, GMA Forte, ...
    American journal of medical genetics Part A 167 (2), 296-312 , 2015
    2015
    Citations: 721
  • Infection-triggered familial or recurrent cases of acute necrotizing encephalopathy caused by mutations in a component of the nuclear pore, RANBP2
    DE Neilson, MD Adams, CMD Orr, DK Schelling, RM Eiben, DS Kerr, ...
    The American Journal of Human Genetics 84 (1), 44-51 , 2009
    2009
    Citations: 419
  • Mutations in VPS33B , encoding a regulator of SNARE-dependent membrane fusion, cause arthrogryposis–renal dysfunction–cholestasis (ARC) syndrome
    P Gissen, CA Johnson, NV Morgan, JM Stapelbroek, T Forshew, ...
    Nature genetics 36 (4), 400-404 , 2004
    2004
    Citations: 388
  • A phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency
    BK Burton, M Balwani, F Feillet, I Barić, TA Burrow, C Camarena Grande, ...
    New England Journal of Medicine 373 (11), 1010-1020 , 2015
    2015
    Citations: 329
  • Guidelines for management of glycogen storage disease type I–European Study on Glycogen Storage Disease Type I (ESGSD I)
    J Rake, G Visser, P Labrune, JV Leonard, K Ullrich, PG Smit
    European Journal of Pediatrics 161 (Suppl 1), S112-S119 , 2002
    2002
    Citations: 295
  • Agenesis of the corpus callosum: clinical and genetic study in 63 young patients
    MF Bedeschi, MC Bonaglia, R Grasso, A Pellegri, RR Garghentino, ...
    Pediatric neurology 34 (3), 186-193 , 2006
    2006
    Citations: 239
  • Mutations in VIPAR cause an arthrogryposis, renal dysfunction and cholestasis syndrome phenotype with defects in epithelial polarization
    AR Cullinane, A Straatman-Iwanowska, A Zaucker, Y Wakabayashi, ...
    Nature genetics 42 (4), 303-312 , 2010
    2010
    Citations: 214
  • Genotype–phenotype correlations and clinical diagnostic criteria in Wolf‐Hirschhorn syndrome
    M Zollino, C Di Stefano, G Zampino, P Mastroiacovo, TJ Wright, G Sorge, ...
    American journal of medical genetics 94 (3), 254-261 , 2000
    2000
    Citations: 210
  • GM1 gangliosidosis and Morquio B disease: an update on genetic alterations and clinical findings
    A Caciotti, SC Garman, Y Rivera-Colón, E Procopio, S Catarzi, L Ferri, ...
    Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1812 (7), 782-790 , 2011
    2011
    Citations: 201
  • Mutations at a single codon in Mad homology 2 domain of SMAD4 cause Myhre syndrome
    C Le Goff, C Mahaut, A Abhyankar, W Le Goff, V Serre, A Afenjar, ...
    Nature genetics 44 (1), 85-88 , 2012
    2012
    Citations: 192
  • Null leukemia inhibitory factor receptor (LIFR) mutations in Stüve-Wiedemann/Schwartz-Jampel type 2 syndrome
    N Dagoneau, D Scheffer, C Huber, LI Al-Gazali, M Di Rocco, A Godard, ...
    The American Journal of Human Genetics 74 (2), 298-305 , 2004
    2004
    Citations: 192
  • Revised recommendations for the management of Gaucher disease in children
    P Kaplan, H Baris, L De Meirleir, M Di Rocco, A El-Beshlawy, M Huemer, ...
    European journal of pediatrics 172 (4), 447-458 , 2013
    2013
    Citations: 182
  • Management goals for type 1 Gaucher disease: An expert consensus document from the European working group on Gaucher disease
    M Biegstraaten, TM Cox, N Belmatoug, MG Berger, T Collin-Histed, ...
    Blood Cells, Molecules, and Diseases 68, 203-208 , 2018
    2018
    Citations: 164
  • Clinical and molecular genetic features of ARC syndrome
    P Gissen, L Tee, CA Johnson, E Genin, A Caliebe, D Chitayat, ...
    Human genetics 120 (3), 396-409 , 2006
    2006
    Citations: 162
  • Clinical features of lysosomal acid lipase deficiency
    BK Burton, PB Deegan, GM Enns, O Guardamagna, S Horslen, ...
    Journal of pediatric gastroenterology and nutrition 61 (6), 619-625 , 2015
    2015
    Citations: 159
  • Cryptic telomeric rearrangements in subjects with mental retardation associated with dysmorphism and congenital malformations
    E Rossi, F Piccini, M Zollino, G Neri, D Caselli, R Tenconi, C Castellan, ...
    Journal of medical genetics 38 (6), 417-420 , 2001
    2001
    Citations: 158
  • Identification and characterization of 15 novel GALC gene mutations causing Krabbe disease
    B Tappino, R Biancheri, M Mort, S Regis, F Corsolini, A Rossi, ...
    Human mutation 31 (12), E1894-E1914 , 2010
    2010
    Citations: 157
  • Mutations in OSTM1 (Grey Lethal) Define a Particularly Severe Form of Autosomal Recessive Osteopetrosis With Neural Involvement
    A Pangrazio, PL Poliani, A Megarbane, G Lefranc, E Lanino, M Di Rocco, ...
    Journal of Bone and Mineral Research 21 (7), 1098-1105 , 2006
    2006
    Citations: 150
  • Natural history of vanishing white matter
    EMC Hamilton, HDW van der Lei, G Vermeulen, JAM Gerver, ...
    Annals of neurology 84 (2), 274-288 , 2018
    2018
    Citations: 145
  • In-frame mutations in exon 1 of SKI cause dominant Shprintzen-Goldberg syndrome
    V Carmignac, J Thevenon, L Adès, B Callewaert, S Julia, ...
    The American Journal of Human Genetics 91 (5), 950-957 , 2012
    2012
    Citations: 144